- Home
- BTE vs BCRX Comparison
BTE vs BCRX Comparison
Compare BTE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTE | BCRX |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BTE | BCRX |
|---|---|---|
| Price | $4.13 | $9.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $20.82 |
| AVG Volume (30 Days) | ★ 18.7M | 4.9M |
| Earning Date | 03-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $35.09 | $12.55 |
| P/E Ratio | $18.43 | ★ $7.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.36 | $6.00 |
| 52 Week High | $4.17 | $11.31 |
Technical Indicators
Market Signals| Indicator | BTE | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.89 | 68.71 |
| Support Level | $3.59 | $7.95 |
| Resistance Level | N/A | $9.18 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 89.87 | 74.91 |
Price Performance
Historical ComparisonAbout BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.